Chondromyxoid fibroma: A tumor showing myofibroblastic, myochondroblastic, and chondrocytic differentiation

Gunnlaugur P. Nielsen, Suzanne B. Keel, G. Richard Dickersin, Martin K. Selig, Atul K. Bhan, Andrew Rosenberg

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Chondromyxoid fibroma (CMF) is a rare primary benign tumor of bone that demonstrates variable histologic features and is often confused with chondrosarcoma. Although the chondroid elements in CMF have been reported to be S-100 protein positive and to have chondrocytic features ultrastructurally, the immunohistochemical and ultrastructural profile of CMF, especially with respect to the peripheral nonchondroid elements, has not been extensively studied. Formalin-fixed, paraffinembedded tissue from 10 CMFs were stained immunohistochemicaily with antibodies to vimentin, desmin, muscle actin, smooth muscle actin, S-100 protein, and CD34. Six tumors were also examined ultrastructurally. The chondroid areas showed variable staining for S-100 protein but did not stain for muscle actin or smooth muscle actin. The peripheral areas surrounding the chondroid areas stained diffusely for smooth muscle actin and muscle actin but did not stain for S-100 protein. CD34 highlighted the extensive vascularity that was especially prominent in the peripheral areas; no tumor cells stained for CD34. There was no staining for desmin. Ultrastructural examination showed three different cell types. Some cells showed the classic features of chondrocytes, other cells had the features of myofibroblasts, and the third cell type had the features of both chondrocytes and myofibroblasts ('myochondroblasts'). These findings support the conclusion that CMF is a tumor showing myofibroblastic, myochondroblastic, and chondrocytic differentiation.

Original languageEnglish
Pages (from-to)514-517
Number of pages4
JournalModern Pathology
Volume12
Issue number5
StatePublished - May 1 1999
Externally publishedYes

Fingerprint

Fibroma
Actins
S100 Proteins
Smooth Muscle
Neoplasms
Desmin
Myofibroblasts
Chondrocytes
Muscles
Coloring Agents
Staining and Labeling
Chondrosarcoma
Vimentin
Formaldehyde
Bone and Bones
Antibodies

Keywords

  • Chondromyxoid fibroma
  • Myochondroblast
  • Myofibroblast

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Nielsen, G. P., Keel, S. B., Dickersin, G. R., Selig, M. K., Bhan, A. K., & Rosenberg, A. (1999). Chondromyxoid fibroma: A tumor showing myofibroblastic, myochondroblastic, and chondrocytic differentiation. Modern Pathology, 12(5), 514-517.

Chondromyxoid fibroma : A tumor showing myofibroblastic, myochondroblastic, and chondrocytic differentiation. / Nielsen, Gunnlaugur P.; Keel, Suzanne B.; Dickersin, G. Richard; Selig, Martin K.; Bhan, Atul K.; Rosenberg, Andrew.

In: Modern Pathology, Vol. 12, No. 5, 01.05.1999, p. 514-517.

Research output: Contribution to journalArticle

Nielsen, GP, Keel, SB, Dickersin, GR, Selig, MK, Bhan, AK & Rosenberg, A 1999, 'Chondromyxoid fibroma: A tumor showing myofibroblastic, myochondroblastic, and chondrocytic differentiation', Modern Pathology, vol. 12, no. 5, pp. 514-517.
Nielsen, Gunnlaugur P. ; Keel, Suzanne B. ; Dickersin, G. Richard ; Selig, Martin K. ; Bhan, Atul K. ; Rosenberg, Andrew. / Chondromyxoid fibroma : A tumor showing myofibroblastic, myochondroblastic, and chondrocytic differentiation. In: Modern Pathology. 1999 ; Vol. 12, No. 5. pp. 514-517.
@article{b7c5be361bc549979a38cca914a5b5ab,
title = "Chondromyxoid fibroma: A tumor showing myofibroblastic, myochondroblastic, and chondrocytic differentiation",
abstract = "Chondromyxoid fibroma (CMF) is a rare primary benign tumor of bone that demonstrates variable histologic features and is often confused with chondrosarcoma. Although the chondroid elements in CMF have been reported to be S-100 protein positive and to have chondrocytic features ultrastructurally, the immunohistochemical and ultrastructural profile of CMF, especially with respect to the peripheral nonchondroid elements, has not been extensively studied. Formalin-fixed, paraffinembedded tissue from 10 CMFs were stained immunohistochemicaily with antibodies to vimentin, desmin, muscle actin, smooth muscle actin, S-100 protein, and CD34. Six tumors were also examined ultrastructurally. The chondroid areas showed variable staining for S-100 protein but did not stain for muscle actin or smooth muscle actin. The peripheral areas surrounding the chondroid areas stained diffusely for smooth muscle actin and muscle actin but did not stain for S-100 protein. CD34 highlighted the extensive vascularity that was especially prominent in the peripheral areas; no tumor cells stained for CD34. There was no staining for desmin. Ultrastructural examination showed three different cell types. Some cells showed the classic features of chondrocytes, other cells had the features of myofibroblasts, and the third cell type had the features of both chondrocytes and myofibroblasts ('myochondroblasts'). These findings support the conclusion that CMF is a tumor showing myofibroblastic, myochondroblastic, and chondrocytic differentiation.",
keywords = "Chondromyxoid fibroma, Myochondroblast, Myofibroblast",
author = "Nielsen, {Gunnlaugur P.} and Keel, {Suzanne B.} and Dickersin, {G. Richard} and Selig, {Martin K.} and Bhan, {Atul K.} and Andrew Rosenberg",
year = "1999",
month = "5",
day = "1",
language = "English",
volume = "12",
pages = "514--517",
journal = "Modern Pathology",
issn = "0893-3952",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Chondromyxoid fibroma

T2 - A tumor showing myofibroblastic, myochondroblastic, and chondrocytic differentiation

AU - Nielsen, Gunnlaugur P.

AU - Keel, Suzanne B.

AU - Dickersin, G. Richard

AU - Selig, Martin K.

AU - Bhan, Atul K.

AU - Rosenberg, Andrew

PY - 1999/5/1

Y1 - 1999/5/1

N2 - Chondromyxoid fibroma (CMF) is a rare primary benign tumor of bone that demonstrates variable histologic features and is often confused with chondrosarcoma. Although the chondroid elements in CMF have been reported to be S-100 protein positive and to have chondrocytic features ultrastructurally, the immunohistochemical and ultrastructural profile of CMF, especially with respect to the peripheral nonchondroid elements, has not been extensively studied. Formalin-fixed, paraffinembedded tissue from 10 CMFs were stained immunohistochemicaily with antibodies to vimentin, desmin, muscle actin, smooth muscle actin, S-100 protein, and CD34. Six tumors were also examined ultrastructurally. The chondroid areas showed variable staining for S-100 protein but did not stain for muscle actin or smooth muscle actin. The peripheral areas surrounding the chondroid areas stained diffusely for smooth muscle actin and muscle actin but did not stain for S-100 protein. CD34 highlighted the extensive vascularity that was especially prominent in the peripheral areas; no tumor cells stained for CD34. There was no staining for desmin. Ultrastructural examination showed three different cell types. Some cells showed the classic features of chondrocytes, other cells had the features of myofibroblasts, and the third cell type had the features of both chondrocytes and myofibroblasts ('myochondroblasts'). These findings support the conclusion that CMF is a tumor showing myofibroblastic, myochondroblastic, and chondrocytic differentiation.

AB - Chondromyxoid fibroma (CMF) is a rare primary benign tumor of bone that demonstrates variable histologic features and is often confused with chondrosarcoma. Although the chondroid elements in CMF have been reported to be S-100 protein positive and to have chondrocytic features ultrastructurally, the immunohistochemical and ultrastructural profile of CMF, especially with respect to the peripheral nonchondroid elements, has not been extensively studied. Formalin-fixed, paraffinembedded tissue from 10 CMFs were stained immunohistochemicaily with antibodies to vimentin, desmin, muscle actin, smooth muscle actin, S-100 protein, and CD34. Six tumors were also examined ultrastructurally. The chondroid areas showed variable staining for S-100 protein but did not stain for muscle actin or smooth muscle actin. The peripheral areas surrounding the chondroid areas stained diffusely for smooth muscle actin and muscle actin but did not stain for S-100 protein. CD34 highlighted the extensive vascularity that was especially prominent in the peripheral areas; no tumor cells stained for CD34. There was no staining for desmin. Ultrastructural examination showed three different cell types. Some cells showed the classic features of chondrocytes, other cells had the features of myofibroblasts, and the third cell type had the features of both chondrocytes and myofibroblasts ('myochondroblasts'). These findings support the conclusion that CMF is a tumor showing myofibroblastic, myochondroblastic, and chondrocytic differentiation.

KW - Chondromyxoid fibroma

KW - Myochondroblast

KW - Myofibroblast

UR - http://www.scopus.com/inward/record.url?scp=0032895325&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032895325&partnerID=8YFLogxK

M3 - Article

C2 - 10349990

AN - SCOPUS:0032895325

VL - 12

SP - 514

EP - 517

JO - Modern Pathology

JF - Modern Pathology

SN - 0893-3952

IS - 5

ER -